Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: A comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers

Neurosurgery

Volumn 43, Issue 4, 1998, Pages 879-885

  Kroll, Robert A ^a   Pagel, Michael A ^b   Muldoon, Leslie L ^a   Roman Goldstein, Simon ^a   Fiamengo, Steven A ^a   Neuwelt, Edward A ^a,b  

^a Department of Neurology ^*  (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Bradykinin; Brain neoplasm; Drug delivery; Mannitol

Indexed keywords

BRADYKININ;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN METASTASIS; BRAIN TUMOR; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; DRUG PENETRATION; HUMAN; LUNG SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOSIS; PRIORITY JOURNAL;

ANIMALS; BLOOD-BRAIN BARRIER; BRADYKININ; BRAIN; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; FEMALE; HUMANS; HYPERTONIC SOLUTIONS; LUNG NEOPLASMS; MANNITOL; NEOPLASM TRANSPLANTATION; RATS; RATS, NUDE; TUMOR CELLS, CULTURED;

EID: 0031720748     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199810000-00090     Document Type: Article

References (30)

1. Barnett PA, Roman-Goldstein S, Ramsey F, McCormick CI, Sexton G, Szumowski J, Neuwelt EA: Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat. Am J Pathol 146:436-449, 1995.
2. Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH: Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. Cancer Res 57:1129-1136, 1997.
3. Black KL, Cloughesy T, Haung SC, Gobin YP, Zhou Y, Grous J, Nelson G, Farahani K, Hoh CK, Phelps M: Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg 86:603-609, 1997.
4. Blasberg RG, Groothuis D, Molnar P: A review of hyperosmotic blood-brain barrier disruption in seven experimental brain tumor models, in Johansson BB, Owman C, Widner H (eds): Pathophysiology of the Blood-Brain Barrier, Amsterdam, Elsevier, 1990, pp 197-220.
5. Chamberlain MC, Murovic JS, Levin VA: Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 38:1371-1374, 1988.
6. Dahlborg SA, Neuwelt EA, Henner WD, Crossen JR, Tableman M, Perrillo A: Non-AIDS primary CNS lymphoma: First example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am 2:166-174, 1996.
7. DeAngelis LM: Cerebral lymphoma presenting as a nonenhancing lesion on a computed tomographic/magnetic resonance scan. Ann Neurol 33:308-311, 1993.
8. Doctrow SR, Abelleira SM, Curry LA, Heller-Harrison R, Kozarich JW, Malfroy B, McCarroll LA, Morgan KG, Morrow AR, Musso GF, Smart JL, Straub JA, Tumbull B, Gloff CA: The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. J Pharmacol Exp Ther 271:229-237, 1994.
9. Elliott PJ, Hayward NJ, Dean RL, Blunt DG, Bartus RT: Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. Cancer Res 56:3998-4005, 1996.
10. Gumerlock MK, Neuwelt EA: Principles of chemotherapy in brain neoplasia, in Jellinger K (ed): Therapy of Malignant Brain Tumors. New York, Springer-Verlag, 1987, pp 277-348.
11. Gumerlock MK, Neuwelt EA: The effects of anesthesia on osmotic blood-brain barrier disruption. Neurosurgery 26:268-277, 1990.
12. Inamura T, Black KL: Bradykinin selectively opens blood-tumor barrier in experimental brain rumors. J Cereb Blood Flow Metab 14:862-870, 1994.
13. Inamura T, Nomura T, Bartus RT, Black KL: Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors. J Neurosurg 81:752-758, 1994.
14. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874, 1987.
15. Lappas DG, Triantafillou A, Griswold JD, Theoharides TC: Anesthetics, in Theoharides TC (ed): Pharmacology. Boston, Little, Brown and Co., 1992, pp 421-464.
16. Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL: Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39:125-133, 1996.
17. Nakano S, Matsukado K, Black KL: Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56:4027-4031, 1996.
18. Neuwelt EA (ed): Implications of the Blood-Brain Barrier and Its Manipulation: Vol. 1 - Basic Science Aspects: Vol. 2 - Clinical Implications. New York, Plenum Press, 1989.
19. Neuwelt EA: Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39:133-134, 1996 (comment).
20. Neuwelt EA, Hill SA: Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases. J Neurooncol 4:195-207, 1987.
21. 35S-herpesvirus across an osmotically modified blood-brain barrier. J Neurosurg 74:475-479, 1991.
22. Neuwelt EA, Weissleder R, Nilaver G, Kroll RA, Roman-Goldstein S, Szumowski J, Pagel MA, Jones RS, Remsen LG, McCormick CI, Shannon EM, Muldoon LL: Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 34:777-784, 1994.
23. Nomura T, Inamura T, Black KL: Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res 659:62-66, 1994.
24. Ohno K, Fredericks WR, Rapoport SI: Osmotic opening of the blood-brain barrier to methotrexate in the rat. Surg Neurol 12: 323-328, 1979.
25. Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ: Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 27:1356-1361, 1991.
26. Rainov NG, Zimmer C, Chase M, Kramm CM, Chiocca EA, Weissleder R, Breakefield XO: Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum Gene Ther 6:1543-1552, 1995.
27. Rapoport SI (ed): Blood-Brain Barrier in Physiology and Medicine. New York, Raven Press, 1976.
28. Rapoport SI, Robinson PJ: Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier. Ann N Y Acad Sci 481:250-267, 1986.
29. Rapoport SI, Fredericks WR, Ohno K, Pettigrew KD: Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol 238:R421-R431, 1980.
30. Raymond JJ, Robertson DM, Dinsdale HB: Pharmacological modification of bradykinin induced breakdown of the blood-brain barrier. Can J Neurol Sci 13:214-220, 1986.